Incomplete angiopoietin-2 knockdown does not confer protection in murine pneumococcal pneumonia

B. Gutbier (Berlin, Germany)

Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Session: Insight into the pathogenesis of emphysema and pneumonia
Session type: Thematic Poster
Number: 3937
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Gutbier (Berlin, Germany). Incomplete angiopoietin-2 knockdown does not confer protection in murine pneumococcal pneumonia. 3937

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Downregulation of RTI40 /T1α protein in pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 719s
Year: 2004

Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008


Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


Role of angiopoietins Ang-1 and Ang-2 for the development of acute lung injury in pneumococcal pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008

Heterologous infection causes pneumonia and impairs alveolar macrophage function in mice
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008

Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016

Airway administration of therapeutic antibody (tAb) confers higher protection than parenteral administration in a murine model of acute lung infection
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018




Pulmonary fibrosis in mice increases susceptibility to pneumococcal pneumonia and bacteremia
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Pulmonary immunostimulation with macrophage-activating lipopeptide-2 in influenza-A-virus infected mice increased survival of subsequent pneumococcal pneumonia
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012

Vaporized perfluorocarbon confers protection against acute lung injury by inhibiting MMP-9 expression without protective effects in other organs
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010

PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011


Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Impact of nasopharyngeal pneumococcal colonization on protective immunity against S. pneumoniae in mice
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Syndecan-1 attenuates lung injury during influenza infection by activating survival signals via c-Met
Source: Lung Science Conference 2015
Year: 2015


Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

The endogenous antibiotic CRAMP is induced during pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 555s
Year: 2004

Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

Performance of the binax NOW Streptococcus pneumoniae urinary antigen assay among children with underlying pulmonary diseases in the absence of acute pneumococcal infection
Source: Eur Respir J 2004; 24: Suppl. 48, 391s
Year: 2004

Enhance protection against nasopharyngeal carriage of Streptococcus pneumoniae elicited by live recombinant attenuated oral salmonella vaccines with PspA‘ and PsaA
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009